Notably, this study represents the first investigation of Irisin in a pathological context and directly implicates Irisin as a potential biomarker of muscle dysfunction with important implications for predicting the onset of sarcopenia and offering new avenues for monitoring age-related changes in muscle function. Here, FNDC5 is linked to sarcopenia.